Current studies have demonstrated oligo-porphyran offers a neuroprotective treatment for Parkinson’s disease via PI3K/Akt/GSK-3β pathway, with changes in the Bax/Bcl-2 ratio [48]. Here, BAX is linked to Parkinson disease.